Ruiz-Bailén, Manuel MD, PhD; Aguayo de Hoyos, Eduardo MD, PhD; Ruiz-Navarro, Silvia MD; Issa-Khozouz, Ziad MD, PhD; Reina-Toral, Antonio MD; Ángel Díaz-Castellanos, Miguel MD; Rodríguez-García, Juan-José MD; Miguel Torres-Ruiz, Juan MD; Cárdenas-Cruz, Antonio MD; Camacho-Víctor, Ángel MD for the ARIAM Group
From the Intensive Care Unit, Critical Care and Emergency Department, Hospital de Poniente, El Ejido, Almería (MR-B, ZI-K, MAD-C, AC-C), Intensive Care Unit, Critical Care and Emergency Department, Hospital Universitario Virgen de las Nieves, Granada (EAH, AR-T, AC-V), Intensive Care Unit, Critical Care and Emergency Department, Complejo Hospitalario Ciudad de Jaén, Jaén (SR-N), Intensive Care Unit, Critical Care and Emergency Department, Hospital Carlos Haya, Málaga (J-JR-G), Intensive Care Unit, Critical Care and Emergency Department, Hospital Universitario San Cecilio, Granada (JMT-R), Spain. The investigators and institutions participating in the ARIAM Group are listed in the Appendix.
Despite the considerable improvement in the treatment of acute myocardial infarction in recent years, the onset of primary or secondary ventricular fibrillation is followed by a very poor prognosis.
*See also p. 2246.
doi: 10.1097/01.CCM.0000079602.14851.EB